Bharat Rasayan Ltd

Bharat Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bharat Rasayan Ltd

₹ 10,924 -1.26%
12 Nov - close price
bharatgroup.co.in BSE: 590021 NSE: BHARATRAS
About

Bharat Rasayan Ltd is engaged in manufacturing Technical Grade Pesticides and Intermediates used in the agro-chemical industry. It was incorporated in 1989.[1]

Key Points

Product Portfolio
The company has a leading market position in many technical and intermediate products, including Lambda Cyhalothrin Technical, Metaphenoxy Benzaldehyde, Metribuzine Technical, Thiamethoxam (Insecticides), Fipronil (Insecticides), etc. It has also added new products like Fluxametamide, Tolfenpyrad Technical, Diuron Technical, etc. Top 10 products account for 66% of total sales. [1]

Website BSE NSE
  • Market Cap ₹ 4,539 Cr.
  • Current Price ₹ 10,924
  • High / Low ₹ 14,284 / 8,333
  • Stock P/E 32.4
  • Book Value ₹ 2,523
  • Dividend Yield 0.01 %
  • ROCE 11.1 %
  • ROE 8.52 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 1.08% over past five years.
  • Dividend payout has been low at 0.53% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
269 335 445 327 292 309 306 239 263 233 310 282 328
229 265 359 275 256 258 247 234 248 205 240 244 273
Operating Profit 40 70 86 52 36 52 59 6 15 28 69 38 55
OPM % 15% 21% 19% 16% 12% 17% 19% 2% 6% 12% 22% 14% 17%
3 -0 7 8 3 6 -3 2 4 4 11 6 7
Interest 1 2 3 2 1 2 1 0 1 1 1 1 1
Depreciation 6 7 7 6 7 7 6 6 6 7 6 6 6
Profit before tax 36 61 83 52 31 49 48 1 12 24 73 37 54
Tax % 26% 25% 23% 25% 26% 26% 32% 46% 34% 27% 23% 27% 25%
27 46 65 39 23 37 33 1 8 17 56 27 40
EPS in Rs 64.69 110.41 155.32 92.92 55.45 88.01 78.48 1.76 18.51 41.59 134.55 64.50 96.62
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
185 360 438 451 618 792 989 1,213 1,091 1,301 1,234 1,044 1,153
159 296 355 370 508 634 802 983 851 1,049 1,037 926 963
Operating Profit 26 64 82 81 111 159 188 230 240 252 197 118 190
OPM % 14% 18% 19% 18% 18% 20% 19% 19% 22% 19% 16% 11% 16%
0 1 1 1 2 4 1 14 6 16 15 21 27
Interest 5 17 18 13 12 12 16 16 4 7 6 3 5
Depreciation 7 18 18 17 16 16 17 22 26 25 26 26 26
Profit before tax 14 30 48 52 84 135 155 205 216 235 180 109 187
Tax % 32% 33% 34% 34% 35% 27% 28% 23% 24% 25% 27% 25%
10 20 32 34 55 98 112 158 164 177 131 82 140
EPS in Rs 22.57 47.43 74.73 79.74 128.35 231.39 262.48 371.03 387.11 426.27 314.85 196.40 337.26
Dividend Payout % 0% 2% 2% 2% 1% 1% 1% 0% 0% 0% 0% 1%
Compounded Sales Growth
10 Years: 11%
5 Years: 1%
3 Years: -1%
TTM: 3%
Compounded Profit Growth
10 Years: 15%
5 Years: -7%
3 Years: -21%
TTM: 74%
Stock Price CAGR
10 Years: 29%
5 Years: 11%
3 Years: 2%
1 Year: 21%
Return on Equity
10 Years: 22%
5 Years: 20%
3 Years: 15%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 4 4 4 4 4 4 4 4 4 4 4 4 4
Reserves 58 78 109 142 196 294 405 560 724 768 897 978 1,044
131 143 140 111 115 128 247 94 58 174 28 80 63
53 82 82 69 54 77 100 94 122 142 152 129 167
Total Liabilities 246 307 335 326 369 504 756 752 908 1,087 1,082 1,192 1,278
135 142 137 136 131 148 150 203 191 228 225 230 235
CWIP 0 1 2 1 1 7 35 18 18 11 11 6 14
Investments 0 0 30 20 0 0 0 9 151 45 75 137 170
111 164 167 169 237 349 570 522 549 803 771 818 859
Total Assets 246 307 335 326 369 504 756 752 908 1,087 1,082 1,192 1,278

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-8 29 60 47 16 29 -52 263 170 -65 213 41
-77 -25 -41 -5 8 -31 -46 -53 -149 64 -43 -76
87 -3 -19 -43 -24 2 102 -169 -40 -25 -152 49
Net Cash Flow 3 1 -0 -1 -0 0 4 40 -19 -26 18 14

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 89 61 66 71 71 102 103 75 99 130 96 138
Inventory Days 108 105 73 71 75 66 112 70 90 120 141 135
Days Payable 56 58 48 32 17 25 24 17 33 30 33 37
Cash Conversion Cycle 141 108 91 110 129 143 191 128 156 221 204 236
Working Capital Days 117 86 75 86 110 127 173 116 134 185 173 227
ROCE % 14% 22% 27% 25% 34% 39% 32% 34% 31% 28% 20% 11%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
75.05% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99% 74.99%
0.00% 0.00% 0.00% 0.53% 0.39% 0.34% 0.35% 0.35% 0.34% 0.34% 0.35% 0.46%
2.28% 2.84% 2.89% 2.57% 2.60% 2.57% 2.57% 2.57% 2.57% 2.57% 2.59% 2.64%
22.67% 22.17% 22.11% 21.91% 22.02% 22.10% 22.09% 22.09% 22.09% 22.09% 22.07% 21.90%
No. of Shareholders 19,31716,74717,38416,37517,30417,23416,36116,05915,39814,66715,15615,889

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings